7 February 2017
3QFY17 Results Update | Sector: Oil & Gas
MRPL
BSE SENSEX
28,335
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val, INRm
Free float (%)
S&P CNX
8,768
MRPL IN
1,753
195.9 / 2.9
116 / 52
-3/44/63
106
11.4
Downgrade to Neutral
EBITDA below est.; forex loss lowers PAT further
MRPL reported 3QFY17 EBITDA of INR13.1b (excl. forex loss of INR1.6b; est. of
INR15.7b; +46% QoQ, +157% YoY), led by lower-than-estimated GRM of
USD7.43/bbl (est. of USD9.3/bbl). Interest cost came in at INR1.4b (est. of
INR1.1b, +25% QoQ, -10% YoY). Other income of INR636m (-31% QoQ, -61%
YoY) missed estimate of INR745m. PAT came in at INR5.7b (est. of INR10.9b,
+36% QoQ, +92% YoY).
Core GRM below estimates:
Core GRM stood at USD5.1/bbl (est. of
USD7.0/bbl), as against USD5.5/bbl in 2QFY17 and USD8.37/bbl in 3QFY16.
GRM has been lower due to the 36-day shutdown of HCU-1 and 5-day
technical shutdown of the polypropylene unit. The company reported
inventory gain of USD2.43/bbl v/s loss of USD0.9/bbl and USD3.57/bbl in
2QFY17 and 3QFY16, respectively. However, according to management,
HCU-1 is up and running, while the polypropylene unit is also running at
+80% utilization since January 2017.
Crude throughput stood at 4.4mmt (+8% QoQ, +14% YoY), reflecting 116%
utilization in the quarter. We believe that the refinery should stabilize at
these levels.
Debt stood at INR70b, against which it has cash balance of INR23.5b. Iran
outstanding payment was only USD102m as of December 2016.
Valuation and view:
Barring such unforeseen technical problems (as seen in this
quarter), we believe that the refinery should be able to report GRM of
USD6.7/bbl in FY18/19. We expect strong operating cash flow of INR30b each
year, excluding working capital changes. The stock trades at 8.1x FY19E EPS and
EV of 4.0x FY19E EBITDA. We value the stock at EV of 5.5x FY19E EBITDA to
arrive at a fair value of INR94/share for the standalone refinery and add INR20
for OMPL (2% upside). The stock has climbed 29% since its last result
announcement. We thus downgrade MRPL to
Neutral with a TP of INR114.
4Q
92,929
-17.6
77,565
15,364
16.5
2,452
1,462
2,394
13,845
77
13,768
343
2
13,424
13,499
15.4
14.5
4.4
9.0
1Q
84,288
-25.5
72,076
12,212
14.5
1,707
1,465
2,295
11,335
0
11,335
4,155
37
7,181
7,181
35.9
8.5
3.7
5.3
FY16 FY17E
FY17
2Q
3Q
4QE
99,690 114,753 124,927 396,474 423,657
-2.5
30.1
34.4
-31.2
6.9
91,835 103,277 113,979 378,593 381,166
7,855 11,476 10,949 17,881 42,491
7.9
10.0
8.8
4.5
10.0
1,681
1,702
1,814
7,122
6,903
1,115
1,395
1,433
5,867
5,409
926
636
682
8,572
4,540
5,984
9,015
8,384 13,464 34,718
0
0
0
1,830
0
5,984
9,015
8,384 11,634 34,718
1,826
3,355
2,794
343 12,130
31
37
33
3
35
4,159
5,660
5,589 11,291 22,588
4,159
5,660
5,589 13,067 22,588
-146.5
91.8
-58.6 -175.2
72.9
4.2
4.9
4.5
3.3
5.3
4.0
5.5
4.2
5.1
4.0
6.9
15.6
6.9
15.9
4.8
(INR Million)
FY17
Var. vs
3QE
est
118,494
-3%
34.4
102,761
1%
15,733
-27%
13.3
1,758
-3%
1,076
30%
745
-15%
13,645
-34%
0
13,645
-34%
2,720
23%
20
10,925
-48%
10,925
-48%
265.3
9.2
4.0
9.3
6%
-45%
CMP: INR112 TP: INR114(+2%)
Financials & Valuations (INR b)
Y/E Mar
2016 2017E
396.5
423.7
Net Sales
17.9
42.5
EBITDA
13.3
22.6
PAT
7.6
12.9
EPS (INR)
NA
70.2
Gr. (%)
36.6
46.5
BV/Sh (INR)
22.6
31.0
RoE (%)
14.3
18.6
RoCE (%)
14.8
8.7
P/E (x)
3.1
2.4
P/BV (x)
2018E
552.9
43.9
22.2
12.7
(1.8)
56.2
24.7
16.7
8.8
2.0
Estimate change
TP change
Rating change
Standalone - Quarterly Earning Model
Y/E March
Net Sales
YoY Cha nge (%)
Tota l Expendi ture
EBITDA
Ma rgi ns (%)
Depreci a ti on
Interes t
Other Income
PBT before EO expense
Extra -Ord expens e
PBT
Ta x
Ra te (%)
Reported PAT
Adj PAT
YoY Cha nge (%)
Ma rgi ns (%)
Key Assumptions
Refi ni ng throughput (mmt)
GRM (USD/bbl )
E: MOSL Es ti ma tes
1Q
113,148
-28.1
105,954
7,194
6.4
1,482
1,223
2,140
6,629
1,542
5,087
1,032
20
4,055
5,284
-1,563.8
4.7
3.9
5.1
FY16
2Q
3Q
102,211 88,187
-35.8 -40.1
111,353 83,721
-9,142 4,466
-8.9
5.1
1,593 1,596
1,627 1,555
2,402 1,636
-9,961 2,951
205
6
-10,166 2,945
-1,032
0
10
0
-9,134 2,945
-8,950 2,951
-8.2 -115.6
-8.8
3.3
3.5
5.3
3.8
8.4
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
Swarnendu Bhushan
(Swarnendu.Bhushan@MotilalOswal.com); +91 22 6129 1529
Abhinil Dahiwale
(Abhinil.Dahiwale@motilaloswal.com); +91 22 3980 4309